Patents by Inventor Cindy Donaldson

Cindy Donaldson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UROCORTIN 2 ANALOGS AND USES THEREOF
    Publication number: 20180271945
    Abstract: Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility compared to urocortin 2, and pharmaceutical compositions of the polypeptides of the present invention. Also disclosed are polynucleotides encoding the polypeptides, and methods of treating pathophysiological states employing pharmaceutical compositions of the polypeptides and polynucleotides of the present invention. In addition, disclosed are vectors and host cells that include a nucleic acid encoding a polypeptide of the present invention, and kits that include pharmaceutical compositions of the present invention.
    Type: Application
    Filed: April 13, 2018
    Publication date: September 27, 2018
    Applicant: Research Development Foundation
    Inventors: Wylie W. VALE, JR., Joan M. VAUGHAN, Cindy DONALDSON, Wolfgang FISCHER, Jean E. F. RIVIER
  • Urocortin 2 analogs and uses thereof
    Patent number: 9572866
    Abstract: Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility compared to urocortin 2, and pharmaceutical compositions of the polypeptides of the present invention. Also disclosed are polynucleotides encoding the polypeptides, and methods of treating pathophysiological states employing pharmaceutical compositions of the polypeptides and polynucleotides of the present invention. In addition, disclosed are vectors and host cells that include a nucleic acid encoding a polypeptide of the present invention, and kits that include pharmaceutical compositions of the present invention.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: February 21, 2017
    Assignee: Research Development Foundation
    Inventors: Wylie W. Vale, Jr., Joan M. Vaughan, Cindy Donaldson, Wolfgang Fischer, Jean E. F. Rivier
  • UROCORTIN 2 ANALOGS AND USES THEREOF
    Publication number: 20160022780
    Abstract: Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility compared to urocortin 2, and pharmaceutical compositions of the polypeptides of the present invention. Also disclosed are polynucleotides encoding the polypeptides, and methods of treating pathophysiological states employing pharmaceutical compositions of the polypeptides and polynucleotides of the present invention. In addition, disclosed are vectors and host cells that include a nucleic acid encoding a polypeptide of the present invention, and kits that include pharmaceutical compositions of the present invention.
    Type: Application
    Filed: October 8, 2015
    Publication date: January 28, 2016
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Wylie W. VALE, JR., Joan M. VAUGHAN, Cindy DONALDSON, Wolfgang FISCHER, Jean E. F. RIVIER
  • UROCORTIN 2 ANALOGS AND USES THEREOF
    Publication number: 20150315257
    Abstract: Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility compared to urocortin 2, and pharmaceutical compositions of the polypeptides of the present invention. Also disclosed are polynucleotides encoding the polypeptides, and methods of treating pathophysiological states employing pharmaceutical compositions of the polypeptides and polynucleotides of the present invention. In addition, disclosed are vectors and host cells that include a nucleic acid encoding a polypeptide of the present invention, and kits that include pharmaceutical compositions of the present invention.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 5, 2015
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Wylie W. VALE, JR., Joan M. VAUGHAN, Cindy DONALDSON, Wolfgang FISCHER, Jean E. F. RIVIER
  • UROCORTIN 2 ANALOGS AND USES THEREOF
    Publication number: 20120238509
    Abstract: Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility compared to urocortin 2, and pharmaceutical compositions of the polypeptides of the present invention. Also disclosed are polynucleotides encoding the polypeptides, and methods of treating pathophysiological states employing pharmaceutical compositions of the polypeptides and polynucleotides of the present invention. In addition, disclosed are vectors and host cells that include a nucleic acid encoding a polypeptide of the present invention, and kits that include pharmaceutical compositions of the present invention.
    Type: Application
    Filed: August 27, 2010
    Publication date: September 20, 2012
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Wylie W. Vale, JR., Mary Elizabeth Vale, Joan M. Vaughan, Cindy Donaldson, Wolfgang Fischer, Jean E. Rivier